How Latent Labs Plans To Create Medicines From Scratch With AI
Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...
Pharm Exec1d
Latent Labs Launches Publicly with $50 Million in Funding for Artificial Intelligence-Powered Programmable Biology
As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...
ProPhase Labs appoints new COO amid executive changes
ProPhase Labs, Inc., a company specializing in pharmaceutical preparations with a current market capitalization of $8.16 million, has announced an executive shift with the departure of its current ...
Latent Labs raises $50M to develop new proteins with AI
Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...
US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy's slump 2-4%
Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...
Nifty Pharma index slips 3%; Natco, Glenmark, Lupin, Laurus down up to 10%
Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.
Pharmabiz3d
Asia Pharma Expo to showcase cutting-edge advancements in mfg
Asia Pharma Expo to showcase cutting-edge advancements in mfg: Our Bureau, Mumbai Tuesday, February 11, 2025, 15:40 Hrs [IST] The 16th Asia Pharma Expo 2025 & Asia Lab Expo 2025, ...